Technical Analysis for ATNM - Actinium Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
F 8.22 -2.26% -0.19
ATNM closed down 2.26 percent on Tuesday, January 26, 2021, on approximately normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical ATNM trend table...

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
1,2,3 Retracement Bearish Bearish Swing Setup 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup -2.26%
Outside Day Range Expansion -2.26%
Wide Bands Range Expansion -2.26%
Up 3 Days in a Row Strength -2.26%
Narrow Range Bar Range Contraction -1.67%
NR7 Range Contraction -1.67%
Older End-of-Day Signals for ATNM ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 2 % about 20 hours ago
1.5x Volume Pace about 21 hours ago
60 Minute Opening Range Breakdown about 22 hours ago
Down 1% about 23 hours ago
Rose Above Previous Day's High about 23 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Actinium Pharmaceuticals, Inc. Description

Actinium Pharmaceuticals, Inc., formerly Cactus Ventures, Inc. is a biopharmaceutical company developing cancer drugs. The Company's advanced products are Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), in human clinical trials for acute myeloid leukemia (AML) and Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used in myeloconditioning for hematopoietic stem cells transplantation (HSCT) in various indications. In addition, the Ac-225 based drugs development relies on the patented Alpha Particle Immunotherapy Technology (APIT) platform technology co-developed with Memorial Sloan- Kettering Cancer Center (MSKCC), a related institution. The APIT technology couples monoclonal antibodies (mAb) with extremely potent but comparatively safe alpha particle emitting radioactive isotopes, in particular actinium 225 and bismuth 213.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Immunology Natural Sciences Immunotherapy Antibodies Monoclonal Antibodies Monoclonal Antibody Chemical Elements Stem Cells Acute Myeloid Leukemia Platform Technology Transplantation Cancer Center Hematopoietic Stem Cell Actinides Bismuth Iodine Cactus Immunotherapy Technology Kettering Cancer Center Memorial Sloan

Is ATNM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 19.47
52 Week Low 4.8
Average Volume 559,757
200-Day Moving Average 9.86
50-Day Moving Average 10.11
20-Day Moving Average 8.40
10-Day Moving Average 8.38
Average True Range 0.49
ADX 37.78
+DI 9.11
-DI 21.44
Chandelier Exit (Long, 3 ATRs ) 9.87
Chandelier Exit (Short, 3 ATRs ) 9.17
Upper Bollinger Band 9.55
Lower Bollinger Band 7.26
Percent B (%b) 0.42
BandWidth 27.27
MACD Line -0.52
MACD Signal Line -0.60
MACD Histogram 0.0777
Fundamentals Value
Market Cap 111.68 Million
Num Shares 13.6 Million
EPS -0.19
Price-to-Earnings (P/E) Ratio -43.72
Price-to-Sales 0.00
Price-to-Book 3.11
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.63
Resistance 3 (R3) 8.65 8.55 8.56
Resistance 2 (R2) 8.55 8.44 8.53 8.53
Resistance 1 (R1) 8.38 8.38 8.33 8.36 8.51
Pivot Point 8.28 8.28 8.25 8.26 8.28
Support 1 (S1) 8.11 8.17 8.06 8.09 7.93
Support 2 (S2) 8.01 8.11 7.99 7.91
Support 3 (S3) 7.84 8.01 7.88
Support 4 (S4) 7.82